Kristina M Deligiannidis (K M Deligiannidis)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 26

Top Venues

Journal of medical economics

Acta psychiatrica Scandinavica

Expert opinion on drug metabolism & toxicology

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Zucker Hillside Hospital

University of Massachusetts Amherst (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Zucker Hillside Hospital

United States

Director, Women's Behavioral Health :: Psychiatry

University of Massachusetts Medical School

United States

Director, Depression Specialty Clinic :: Psychiatry

Education History

University of Massachusetts Amherst

United States

BSC :: Psychology

University of Massachusetts Amherst

United States

BSC :: Biology

Publications

Samantha E Meltzer-Brody, Margaret E Gerbasi, Catherine Mak, Youssef Toubouti, Sarah Smith, Neil Roskell, Robin Tan, Shih-Yin Sharon Chen, Kristina M Deligiannidis
Indirect comparisons of relative efficacy estimates of zuranolone and selective serotonin reuptake inhibitors for postpartum depression. Journal of medical economics 27 (1) (2024)
Lasair O'Callaghan, Elizabeth Chertavian, Scott J Johnson, Erin Ferries, Kristina M Deligiannidis
The cost-effectiveness of zuranolone versus selective serotonin reuptake inhibitors for the treatment of postpartum depression in the United States. Journal of medical economics 27 (1) (2024)
Samantha E Meltzer-Brody, Margaret E Gerbasi, C Mak, Y Toubouti, Sarah Smith, Neil Roskell, Robin Tan, Shih-Yin Sharon Chen, Kristina M Deligiannidis
Indirect comparisons of relative efficacy estimates of zuranolone and selective serotonin reuptake inhibitors for postpartum depression. Journal of medical economics (2024)
Megan M Hare, Anita Barber, Scott A Shaffer, Kristina M Deligiannidis
Bidirectional associations between perinatal allopregnanolone and depression severity with postpartum gray matter volume in adult women. Acta psychiatrica Scandinavica (2024)
Samantha E Meltzer-Brody, Margaret E Gerbasi, Catherine Mak, Youssef Toubouti, Sarah Smith, Neil Roskell, Robin Tan, Shih-Yin Sharon Chen, Kristina M Deligiannidis
Indirect comparisons of relative efficacy estimates of zuranolone and selective serotonin reuptake inhibitors for postpartum depression. Journal of medical economics 27 (1) (2024)
Samantha E Meltzer-Brody, Margaret E Gerbasi, Catherine Mak, Youssef Toubouti, Sarah Smith, Neil Roskell, Robin Tan, Shih-Yin Sharon Chen, Kristina M Deligiannidis
Indirect comparisons of relative efficacy estimates of zuranolone and selective serotonin reuptake inhibitors for postpartum depression. Journal of medical economics 27 (1) (2024)
Lasair O'Callaghan, Elizabeth Chertavian, Scott J Johnson, Erin Ferries, Kristina M Deligiannidis
The cost-effectiveness of zuranolone versus selective serotonin reuptake inhibitors for the treatment of postpartum depression in the United States. Journal of medical economics (2024)
Kristina M Deligiannidis, Jennifer L Payne
Progress in perinatal mental health research. Acta psychiatrica Scandinavica (2024)
Kristina M Deligiannidis
Question: How Should I Manage Medications for A Patient With A History of Bipolar Disorder Who Would Like to Become Pregnant? Journal of clinical psychopharmacology 44 (4) (2024)
Kristina M Deligiannidis, Jennifer L Payne
Progress in perinatal mental health research. Acta psychiatrica Scandinavica (2024)
Lasair O'Callaghan, Elizabeth Chertavian, Scott J Johnson, Erin Ferries, Kristina M Deligiannidis
The cost-effectiveness of zuranolone versus selective serotonin reuptake inhibitors for the treatment of postpartum depression in the United States. Journal of medical economics 27 (1) (2024)
Samantha E Meltzer-Brody, Margaret E Gerbasi, Catherine Mak, Youssef Toubouti, Sarah Smith, Neil Roskell, Robin Tan, Shih-Yin Sharon Chen, Kristina M Deligiannidis
Indirect comparisons of relative efficacy estimates of zuranolone and selective serotonin reuptake inhibitors for postpartum depression. Journal of medical economics 27 (1) (2024)
Sara V Carlini, Lauren M Osborne, Kristina M Deligiannidis
Current pharmacotherapy approaches and novel GABAergic antidepressant development in postpartum depression. Dialogues in clinical neuroscience 25 (1) (2023)
Georgios Schoretsanitis, Kristina M Deligiannidis, Michael Paulzen, Edoardo Spina, Jose De Leon
Drug-drug interactions between psychotropic medications and oral contraceptives. Expert opinion on drug metabolism & toxicology 18 (6) (2022)
Sara V Carlini, Sandra J Weiss, Lauren Mordukhaev, Sunu Jacob, Heather A Flynn, Kristina M Deligiannidis
Clinical correlates of women endorsing premenstrual suicidal ideation: a cross-sectional study. BioPsychoSocial medicine 16 (1) (2022)
Yardana Kaufman, Sara V Carlini, Kristina M Deligiannidis
Advances in pharmacotherapy for postpartum depression: a structured review of standard-of-care antidepressants and novel neuroactive steroid antidepressants. Therapeutic advances in psychopharmacology 12 (2022)
Sara V Carlini, Teresa Lanza di Scalea, Stephanie Trentacoste McNally, Janice Lester, Kristina M Deligiannidis
Management of Premenstrual Dysphoric Disorder: A Scoping Review. International journal of women's health 14 (2022)
Sara V Carlini, Teresa Lanza di Scalea, Stephanie Trentacoste McNally, Janice Lester, Kristina M Deligiannidis
Management of Premenstrual Dysphoric Disorder: A Scoping Review. International journal of women's health 14 (2022)
Sara V Carlini, Kristina M Deligiannidis
Poor neonatal adaptation syndrome: Toward a clinical consensus to guide research and counseling. Acta psychiatrica Scandinavica (2021)
Ariela Frieder, Madeleine Fersh, Rachel Hainline, Kristina M Deligiannidis
Pharmacotherapy of Postpartum Depression: Current Approaches and Novel Drug Development. CNS drugs 33 (3) (2020)
Megan M Hare, Aimee Kroll-Desrosiers, Kristina M Deligiannidis
Peripartum depression: Does risk versus diagnostic status impact mother-infant bonding and perceived social support? Depression and anxiety 38 (4) (2020)
Georgios Schoretsanitis, Olav Spigset, Julia C Stingl, Kristina M Deligiannidis, Michael Paulzen, Andreas A Westin
The impact of pregnancy on the pharmacokinetics of antidepressants: a systematic critical review and meta-analysis. Expert opinion on drug metabolism & toxicology 16 (5) (2020)
Christy Duan, Megan M Hare, Morganne Staring, Kristina M Deligiannidis
Examining the relationship between perinatal depression and neurodevelopment in infants and children through structural and functional neuroimaging research. International review of psychiatry (Abingdon, England) 31 (3) (2019)
Michelle Silver, Constance M Moore, Vanessa Villamarin, Nina Jaitly, Janet E Hall, Anthony J Rothschild, Kristina M Deligiannidis
White matter integrity in medication-free women with peripartum depression: a tract-based spatial statistics study. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 43 (7) (2018)
Kristina M Deligiannidis, Christina L Fales, Aimee R Kroll-Desrosiers, Scott A Shaffer, Vanessa Villamarin, Yanglan Tan, Janet E Hall, Blaise B Frederick, Elif M Sikoglu, Richard A Edden, Anthony J Rothschild, Constance M Moore
Resting-state functional connectivity, cortical GABA, and neuroactive steroids in peripartum and peripartum depressed women: a functional magnetic resonance imaging and spectroscopy study. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 44 (3) (2018)
Kristina M Deligiannidis, Aimee R Kroll-Desrosiers, Abby Svenson, Nina Jaitly, Bruce A Barton, Janet E Hall, Anthony J Rothschild
Cortisol response to the Trier Social Stress Test in pregnant women at risk for postpartum depression. Archives of women's mental health 19 (5) (2016)

Kristina M Deligiannidis.css-eqlu8i{font-size:small;padding-left:4px;} (K M Deligiannidis)

Publication Activity (10 Years)

Top Topics

Top Venues

Kristina M Deligiannidis (K M Deligiannidis)